Their ability to influence inflammasome pathways, especially NLRP3, has shown effectiveness in reducing excessive inflammation and mitigating chronic inflammatory conditions such as IgA nephropathy, cardiac fibrosis, and colitis. Here, NLRP3 is linked to IgA glomerulonephritis.